- CMRX has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $16.1 million.
- CMRX has traded 88,341 shares today.
- CMRX is up 3% today.
- CMRX was down 6.1% yesterday.
EXCLUSIVE OFFER: Get the inside scoop on opportunities in CMRX with the Ticky from Trade-Ideas. See the FREE profile for CMRX NOW at Trade-Ideas More details on CMRX: Chimerix, Inc., a biopharmaceutical company, discovers, develops, and commercializes novel, oral antivirals to address unmet medical needs in the United States. Currently there are 6 analysts that rate Chimerix a buy, no analysts rate it a sell, and none rate it a hold. The average volume for Chimerix has been 1.2 million shares per day over the past 30 days. Chimerix has a market cap of $1.4 billion and is part of the health care sector and drugs industry. Shares are up 143.9% year-to-date as of the close of trading on Wednesday. STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more. TheStreetRatings.com Analysis: TheStreet Quant Ratings rates Chimerix as a hold. The company's strengths can be seen in multiple areas, such as its solid stock price performance, revenue growth and largely solid financial position with reasonable debt levels by most measures. However, as a counter to these strengths, we also find weaknesses including feeble growth in the company's earnings per share, deteriorating net income and weak operating cash flow.